- Home
- FBLG vs ME Comparison
FBLG vs ME Comparison
Compare FBLG & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLG
- ME
- Stock Information
- Founded
- FBLG 2021
- ME 2006
- Country
- FBLG United States
- ME United States
- Employees
- FBLG N/A
- ME N/A
- Industry
- FBLG
- ME Precision Instruments
- Sector
- FBLG
- ME Health Care
- Exchange
- FBLG NYSE
- ME Nasdaq
- Market Cap
- FBLG 67.7M
- ME 68.4M
- IPO Year
- FBLG 2024
- ME N/A
- Fundamental
- Price
- FBLG $1.13
- ME $2.42
- Analyst Decision
- FBLG Strong Buy
- ME Hold
- Analyst Count
- FBLG 4
- ME 1
- Target Price
- FBLG $13.00
- ME $9.40
- AVG Volume (30 Days)
- FBLG 524.8K
- ME 235.7K
- Earning Date
- FBLG 03-04-2025
- ME 01-28-2025
- Dividend Yield
- FBLG N/A
- ME N/A
- EPS Growth
- FBLG N/A
- ME N/A
- EPS
- FBLG N/A
- ME N/A
- Revenue
- FBLG N/A
- ME $208,775,000.00
- Revenue This Year
- FBLG N/A
- ME $22.00
- Revenue Next Year
- FBLG N/A
- ME $17.31
- P/E Ratio
- FBLG N/A
- ME N/A
- Revenue Growth
- FBLG N/A
- ME N/A
- 52 Week Low
- FBLG $1.06
- ME $2.42
- 52 Week High
- FBLG $14.70
- ME $13.74
- Technical
- Relative Strength Index (RSI)
- FBLG 32.20
- ME 32.49
- Support Level
- FBLG $1.12
- ME $2.42
- Resistance Level
- FBLG $1.32
- ME $2.96
- Average True Range (ATR)
- FBLG 0.20
- ME 0.19
- MACD
- FBLG -0.03
- ME 0.01
- Stochastic Oscillator
- FBLG 6.91
- ME 0.00
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.